drugset / Trial / NCT04472988

Eye Movement Desensitization and Reprocessing on Autoimmune Thyroiditis in Adults

NCT04472988

Completed 91 enrolled University of Bucharest
RandomizedParallel-groupSingle-blindSupportive care

Summary

The purpose of this study is to evaluate whether Eye Movement Desensitization and Reprocessing (EMDR) is effective in decreasing the level of autoantibodies of patients with autoimmune thyroiditis. The investigators hypothesize that processing traumatic memories from events that happened before the illness onset will have a positive impact first on the psyche (a) by decreasing the level of dissociation, alexithymia, anger, and (b) by increasing the quality of life and emotional regulation, than those in the control group. Secondly, it will have an impact on the biological level, by decreasing the level of autoantibodies, antithyroglobulin antibody (anti-Tg) and anti-thyroid peroxidase antibody (anti-TPO), which are the main antibodies detected in chronic autoimmune thyroiditis.

Timeline

Start
2020-01-01
Primary completion
2020-12-05
Completion
2021-03-23

Drugs

EvaluationDrugModalityDoseRoute
Background Levothyroxine Other / unclassified

Indications